STAT News
JANUARY 7, 2023
Joan Cohrs missed her chance to grab a prescription at her usual drugstore by about 30 seconds. Cohrs walked up to the counter of an Indianapolis CVS pharmacy shortly after a metal curtain descended, closing it for lunch. She didn’t mind. The 60-year-old said she feels compassion for people in health care.
Medical Xpress
JANUARY 7, 2023
The Dutch and Portuguese governments on Friday joined a growing number of nations requiring air passengers arriving from China to show a negative COVID-19 test upon entry.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
NPR Health - Shots
JANUARY 7, 2023
Does the idea of ambitious goal-setting in January turn you off? Try these tips for sustainable self-care instead.
Medical Xpress
JANUARY 7, 2023
The human brain holds many clues about a person's long-term health—in fact, research shows that a person's brain age is a more useful and accurate predictor of health risks and future disease than their birthdate. Now, a new artificial intelligence (AI) model that analyzes magnetic resonance imaging (MRI) brain scans developed by USC researchers could be used to accurately capture cognitive decline linked to neurodegenerative diseases like Alzheimer's much earlier than previous methods.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
STAT News
JANUARY 7, 2023
When the Food and Drug Administration lifted some — but not all — of its restrictions on an abortion pill this week, it raised questions about why these rules were there in the first place. Mifepristone, the drug in question, has been used by over 3.7 million Americans to end early pregnancies since its approval in 2000, is more than 97% effective, tends to have only mild side effects such as cramping, with severe ones occurring in fewer than 0.5% of patients.
Medical Xpress
JANUARY 7, 2023
Research by two Texas A&M University scientists is focused on improving Lyme disease treatment outcomes by developing a test that's both more accurate and more efficient than the current test for the infection.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Medical Xpress
JANUARY 7, 2023
An antidote to teenage depression might be found in school gymnasiums and on sports fields, a major new review argues.
BioSpace
JANUARY 7, 2023
Following difficult recent months for EQRx, the biotech is being bought by Revolution Medicines in an all-stock transaction that secures $1 billion in additional capital for the oncology company.
Drug Patent Watch
JANUARY 7, 2023
This chart shows the pharmaceutical companies with the most patents in Hungary. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Hungary? appeared first on DrugPatentWatch - Make Better Decisions.
BioSpace
JANUARY 7, 2023
In its second-quarter earnings reported Tuesday, Pfizer announced total revenues declined 54% to $12.7 billion, primarily due to a plummet in Paxlovid and Comirnaty sales.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Drug Patent Watch
JANUARY 7, 2023
Brimonidine tartrate is the generic ingredient in nine branded drugs marketed by Padagis Israel, Galderma Labs Lp, Allergan, Akorn, Apotex, Bausch And Lomb, Indoco, Sandoz Inc, Somerset Theraps Llc, Teva…. The post New tentative approval for Slayback Pharma drug brimonidine tartrate appeared first on DrugPatentWatch - Make Better Decisions.
BioSpace
JANUARY 7, 2023
The settlement agreement between the companies follows three patent-infringement lawsuits filed by Bristol-Myers Squibb over the blockbuster cancer immunotherapies.
BioSpace
JANUARY 7, 2023
The FDA has approved Jemperli as an add-on to chemotherapy for patients with primary advanced or recurrent endometrial cancer that is mismatch repair deficient or microsatellite instability-high.
Expert insights. Personalized for you.
145 
Let's personalize your content